These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 81931)

  • 1. Cyclic A.M.P. and arrhythmias revisited.
    Opie LH; Muller CA; Lubbe WF
    Lancet; 1978 Oct; 2(8096):921-3. PubMed ID: 81931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrhythmic drugs.
    Podzuweit T; Lubbe WF; Opie LH
    Lancet; 1976 Feb; 1(7955):341-2. PubMed ID: 54744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical aspects of arrhythmogenesis and ventricular fibrillation.
    Opie LH; Nathan D; Lubbe WF
    Am J Cardiol; 1979 Jan; 43(1):131-48. PubMed ID: 31786
    [No Abstract]   [Full Text] [Related]  

  • 4. Myocardial metabolism and heart disease.
    Opie LH
    Jpn Circ J; 1978 Nov; 42(11):1223-47. PubMed ID: 34741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenine nucleotides and ventricular fibrillation.
    Lubbe WF; Gilchrist AI; Holland RK; Pybus J
    J Mol Cell Cardiol; 1987 Oct; 19 Suppl 5():23-33. PubMed ID: 2448489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of myocardial cyclic AMP and vulnerability to fibrillation in the rat heart.
    Lubbe WF; Nguyen T; West EJ
    Fed Proc; 1983 May; 42(8):2460-4. PubMed ID: 6301887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of propranolol isomers and atenolol on myocardial cyclic AMP, high energy phosphates and vulnerability to fibrillation after coronary artery ligation in the isolated rat heart.
    Lubbe WF; Muller CA; Worthington M; McFadyen EL; Opie LH
    Cardiovasc Res; 1981 Dec; 15(12):690-9. PubMed ID: 6275992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cyclic AMP levels in the plasma and ischemic myocardium and free fatty-acid levels in the serum following coronary artery ligation in dogs: relation to ventricular fibrillation].
    Huang DX; Dong J
    Zhonghua Nei Ke Za Zhi; 1989 Aug; 28(8):457-9, 507-8. PubMed ID: 2557190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cyclic adenosine monophosphate in adrenergic effects on ventricular vulnerability to fibrillation in the isolated perfused rat heart.
    Lubbe WF; Podzuweit T; Daries PS; Opie LH
    J Clin Invest; 1978 May; 61(5):1260-9. PubMed ID: 207734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship among myocardial norepinephrine, cyclic AMP and ventricular fibrillation in experimental infarction].
    Ogawa K; Kanayama H; Ban M; Satake T
    Kokyu To Junkan; 1985 Nov; 33(11):1305-10. PubMed ID: 3006199
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclic AMP levels in ischaemic and non-ischaemic myocardium following coronary artery ligation: relation to ventricular fibrillation.
    Podzuweit T; Dalby AJ; Cherry GW; Opie LH
    J Mol Cell Cardiol; 1978 Jan; 10(1):81-94. PubMed ID: 202713
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of verapamil and its isomers on vulnerability to ventricular fibrillation during acute myocardial ischemia and adrenergic stimulation in isolated rat heart.
    Thandroyen FJ; Higginson L; Opie LH
    J Mol Cell Cardiol; 1986 Jun; 18(6):645-9. PubMed ID: 2426459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic responses to varying restrictions of coronary blood flow in swine.
    Liedtke AJ; Hughes HC; Neely JR
    Am J Physiol; 1975 Feb; 228(2):655-62. PubMed ID: 1119586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of arrhythmia associated with myocardial infarction--based on experimental ischemic ventricular arrhythmia and bradyarrhythmia].
    Kasanuki H
    Kokyu To Junkan; 1984 Dec; 32(12):1235-44. PubMed ID: 6098946
    [No Abstract]   [Full Text] [Related]  

  • 15. Physical training increases ventricular fibrillation thresholds of isolated rat hearts during normoxia, hypoxia and regional ischemia.
    Noakes TD; Higginson L; Opie LH
    Circulation; 1983 Jan; 67(1):24-30. PubMed ID: 6291806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Cyclic A.M.P. and arrhythmias.
    de Gaetano G; Donati MB; Bonaccorsi A; Franco R; Dejana E; Buczko W
    Lancet; 1976 Apr; 1(7964):864. PubMed ID: 56686
    [No Abstract]   [Full Text] [Related]  

  • 17. Duration of asystolic reperfusion and reperfusate electrolyte composition influence postcardioplegia ventricular fibrillation.
    Holman WL; Spruell RD; Pacifico AD
    J Thorac Cardiovasc Surg; 1993 Sep; 106(3):511-9. PubMed ID: 8361195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamine-mediated arrhythmias in acute myocardial infarction. Experimental evidence and role of beta-adrenoceptor blockade.
    Opie LH; Lubbe WF
    S Afr Med J; 1979 Nov; 56(22):871-80. PubMed ID: 42151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic AMP mediated arrhythmias induced in the ischaemic pig heart.
    Podzuweit T; Els DJ; McCarthy J
    Basic Res Cardiol; 1981; 76(4):443-8. PubMed ID: 6116488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship to ventricular fibrillation of early tissue sodium and potassium shifts and coronary vein potassium levels in experimental myocardial infarction.
    Cherry G; Myers MB
    J Thorac Cardiovasc Surg; 1971 Apr; 61(4):587-98. PubMed ID: 5552706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.